Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
Background Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its imp...
Uloženo v:
| Vydáno v: | Allergy (Copenhagen) Ročník 73; číslo 8; s. 1622 - 1631 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Denmark
Blackwell Publishing Ltd
01.08.2018
Wiley |
| Témata: | |
| ISSN: | 0105-4538, 1398-9995, 1398-9995 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.
Methods
We undertook a 1‐year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as “Low” burden and VAS levels ≥50/100 as “High” burden.
Results
Visual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis‐driven patterns were defined based on “Low” and “High” VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High—Asthma Low pattern. There were 1.7% days with a Rhinitis High—Asthma High—Conjunctivitis Low pattern. A novel Rhinitis High—Asthma High—Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.
Conclusions
In a novel approach examining daily symptoms with mobile technology, we found considerable intra‐individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. |
|---|---|
| AbstractList | Background
Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.
Methods
We undertook a 1‐year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as “Low” burden and VAS levels ≥50/100 as “High” burden.
Results
Visual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis‐driven patterns were defined based on “Low” and “High” VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High—Asthma Low pattern. There were 1.7% days with a Rhinitis High—Asthma High—Conjunctivitis Low pattern. A novel Rhinitis High—Asthma High—Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.
Conclusions
In a novel approach examining daily symptoms with mobile technology, we found considerable intra‐individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. BackgroundMultimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.MethodsWe undertook a 1‐year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as “Low” burden and VAS levels ≥50/100 as “High” burden.ResultsVisual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis‐driven patterns were defined based on “Low” and “High” VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High—Asthma Low pattern. There were 1.7% days with a Rhinitis High—Asthma High—Conjunctivitis Low pattern. A novel Rhinitis High—Asthma High—Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.ConclusionsIn a novel approach examining daily symptoms with mobile technology, we found considerable intra‐individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. BackgroundMultimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary. MethodsWe undertook a 1-year prospective observational study in which 4 210 users and 32585days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as "Low" burden and VAS levels 50/100 as "High" burden. ResultsVisual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on "Low" and "High" VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis HighAsthma Low pattern. There were 1.7% days with a Rhinitis HighAsthma HighConjunctivitis Lowpattern. A novel Rhinitis HighAsthma HighConjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels. ConclusionsIn a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.BACKGROUNDMultimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.We undertook a 1-year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as "Low" burden and VAS levels ≥50/100 as "High" burden.METHODSWe undertook a 1-year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as "Low" burden and VAS levels ≥50/100 as "High" burden.Visual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on "Low" and "High" VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High-Asthma Low pattern. There were 1.7% days with a Rhinitis High-Asthma High-Conjunctivitis Low pattern. A novel Rhinitis High-Asthma High-Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.RESULTSVisual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on "Low" and "High" VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High-Asthma Low pattern. There were 1.7% days with a Rhinitis High-Asthma High-Conjunctivitis Low pattern. A novel Rhinitis High-Asthma High-Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.In a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity.CONCLUSIONSIn a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary. We undertook a 1-year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as "Low" burden and VAS levels ≥50/100 as "High" burden. Visual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on "Low" and "High" VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High-Asthma Low pattern. There were 1.7% days with a Rhinitis High-Asthma High-Conjunctivitis Low pattern. A novel Rhinitis High-Asthma High-Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels. In a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. BACKGROUND:Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.METHODS:We undertook a 1-year prospective observational study in which 4 210 users and 32 585 days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as "Low" burden and VAS levels ≥50/100 as "High" burden.RESULTS:Visual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on "Low" and "High" VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis High-Asthma Low pattern. There were 1.7% days with a Rhinitis High-Asthma High-Conjunctivitis Low pattern. A novel Rhinitis High-Asthma High-Conjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels.CONCLUSIONS:In a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity. |
| Author | Kull, I. Kowalski, M. L. Bousquet, J. Rodriguez Gonzalez, M. Cartier, C. Valiulis, A. Westman, M. Valovirta, E. Silva, J. VandenPlas, O. Bergmann, K. C. van Eerd, M. Sarquis‐Serpa, F. Annesi‐Maesano, I. Bieber, T. Ventura, M. T. Gemicioğlu, B. Menditto, E. Bourret, R. Pfaar, O. Samolinski, B. Anto, J. M. Demoly, P. Stelmach, R. Bedbrook, A. Melén, E. Just, J. Shamai, S. Laune, D. Burguete Cabañas, M. T. Kupczyk, M. Spranger, O. Ballardini, N. Haahtela, T. Stellato, C. Todo Bom, A. Ryan, D. Wickman, M. Bindslev‐Jensen, C. Eller, E. Chavannes, N. H. Arnavielhe, S. Sheikh, A. Bachert, C. Larenas‐Linnemann, D. Klimek, L. Bosnic‐Anticevich, S. Fokkens, W. J. Murray, R. Fonseca, J. A. Mösges, R. Zuberbier, T. Mullol, J. Triggiani, M. Yorgancioglu, A. Viart, F. Kvedariene, V. Portejoie, F. Toppila‐Salmi, S. K. Kuna, P. Raciborski, F. Bewick, M. Cruz, A. A. Bosse, I. Valero, A. Passalacqua, G. Casale, T. Keil, T. Vezzani, G. Tomazic, P. V. Ivancevich, J. C. Sorensen, M. Siroux, V. Hellings, P. W. O'Hehir, R. E. Caimmi, D. Devillier, P. Agache, I. De Vries, G. Morais Alme |
| Author_xml | – sequence: 1 givenname: J. surname: Bousquet fullname: Bousquet, J. email: jean.bousquet@orange.fr organization: Charité – sequence: 2 givenname: P. orcidid: 0000-0003-4107-8317 surname: Devillier fullname: Devillier, P. organization: Suresnes Université Versailles Saint‐Quentin – sequence: 3 givenname: J. M. surname: Anto fullname: Anto, J. M. organization: Universitat Pompeu Fabra (UPF) – sequence: 4 givenname: M. surname: Bewick fullname: Bewick, M. organization: iQ4U Consultants Ltd – sequence: 5 givenname: T. surname: Haahtela fullname: Haahtela, T. organization: Helsinki University Hospital – sequence: 6 givenname: S. surname: Arnavielhe fullname: Arnavielhe, S. organization: Kyomed – sequence: 7 givenname: A. surname: Bedbrook fullname: Bedbrook, A. organization: Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site – sequence: 8 givenname: R. surname: Murray fullname: Murray, R. organization: MedScript Ltd – sequence: 9 givenname: M. surname: van Eerd fullname: van Eerd, M. organization: Peercode DV – sequence: 10 givenname: J. A. surname: Fonseca fullname: Fonseca, J. A. organization: Universidade do Porto – sequence: 11 givenname: M. surname: Morais Almeida fullname: Morais Almeida, M. organization: Hospital CUF‐Descobertas – sequence: 12 givenname: A. surname: Todo Bom fullname: Todo Bom, A. organization: University of Coimbra – sequence: 13 givenname: E. surname: Menditto fullname: Menditto, E. organization: University of Naples Federico II – sequence: 14 givenname: G. surname: Passalacqua fullname: Passalacqua, G. organization: University of Genoa – sequence: 15 givenname: C. orcidid: 0000-0002-1294-8355 surname: Stellato fullname: Stellato, C. organization: University of Salerno – sequence: 16 givenname: M. surname: Triggiani fullname: Triggiani, M. organization: University of Salerno – sequence: 17 givenname: M. T. surname: Ventura fullname: Ventura, M. T. organization: University of Bari Medical School – sequence: 18 givenname: G. surname: Vezzani fullname: Vezzani, G. organization: AUSL di Reggio Emilia – sequence: 19 givenname: I. surname: Annesi‐Maesano fullname: Annesi‐Maesano, I. organization: UPMC Sorbonne Universités – sequence: 20 givenname: R. surname: Bourret fullname: Bourret, R. organization: Centre Hospitalier – sequence: 21 givenname: I. surname: Bosse fullname: Bosse, I. organization: Allergist – sequence: 22 givenname: D. surname: Caimmi fullname: Caimmi, D. organization: Sorbonne Universités – sequence: 23 givenname: C. surname: Cartier fullname: Cartier, C. organization: ASA ‐ Advanced Solutions Accelerator – sequence: 24 givenname: P. surname: Demoly fullname: Demoly, P. organization: Sorbonne Universités – sequence: 25 givenname: J. surname: Just fullname: Just, J. organization: Sorbonne Universités – sequence: 26 givenname: F. orcidid: 0000-0001-9226-7762 surname: Portejoie fullname: Portejoie, F. organization: Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site – sequence: 27 givenname: V. orcidid: 0000-0001-7329-7237 surname: Siroux fullname: Siroux, V. organization: Université Joseph Fourier – sequence: 28 givenname: F. surname: Viart fullname: Viart, F. organization: ASA ‐ Advanced Solutions Accelerator – sequence: 29 givenname: K. C. surname: Bergmann fullname: Bergmann, K. C. organization: Global Allergy and Asthma European Network (GA2LEN) – sequence: 30 givenname: T. surname: Keil fullname: Keil, T. organization: University of Wuerzburg – sequence: 31 givenname: L. surname: Klimek fullname: Klimek, L. organization: Heidelberg University – sequence: 32 givenname: R. surname: Mösges fullname: Mösges, R. organization: CRI‐Clinical Research International‐Ltd – sequence: 33 givenname: O. surname: Pfaar fullname: Pfaar, O. organization: Heidelberg University – sequence: 34 givenname: S. surname: Shamai fullname: Shamai, S. organization: University of Cologne – sequence: 35 givenname: T. surname: Zuberbier fullname: Zuberbier, T. organization: Global Allergy and Asthma European Network (GA2LEN) – sequence: 36 givenname: J. surname: Mullol fullname: Mullol, J. organization: University of Barcelona – sequence: 37 givenname: A. surname: Valero fullname: Valero, A. organization: University of Barcelona – sequence: 38 givenname: O. surname: Spranger fullname: Spranger, O. organization: Global Allergy and Asthma Platform GAAPP – sequence: 39 givenname: P. V. surname: Tomazic fullname: Tomazic, P. V. organization: Medical University of Graz – sequence: 40 givenname: M. L. surname: Kowalski fullname: Kowalski, M. L. organization: Medical University of Lodz – sequence: 41 givenname: P. surname: Kuna fullname: Kuna, P. organization: Medical University of Lodz – sequence: 42 givenname: M. surname: Kupczyk fullname: Kupczyk, M. organization: Medical University of Lodz – sequence: 43 givenname: F. surname: Raciborski fullname: Raciborski, F. organization: Medical University of Warsaw – sequence: 44 givenname: B. surname: Samolinski fullname: Samolinski, B. organization: Medical University of Warsaw – sequence: 45 givenname: S. K. surname: Toppila‐Salmi fullname: Toppila‐Salmi, S. K. organization: Helsinki University Hospital – sequence: 46 givenname: E. surname: Valovirta fullname: Valovirta, E. organization: Terveystalo Allergy Clinic – sequence: 47 givenname: A. A. surname: Cruz fullname: Cruz, A. A. organization: GARD Executive Committee – sequence: 48 givenname: F. surname: Sarquis‐Serpa fullname: Sarquis‐Serpa, F. organization: Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria – sequence: 49 givenname: J. surname: Silva fullname: Silva, J. organization: Federal University of Santa Catarina (HU‐UFSC) – sequence: 50 givenname: R. surname: Stelmach fullname: Stelmach, R. organization: Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo – sequence: 51 givenname: D. surname: Larenas‐Linnemann fullname: Larenas‐Linnemann, D. organization: Hospital Médica Sur – sequence: 52 givenname: M. surname: Rodriguez Gonzalez fullname: Rodriguez Gonzalez, M. organization: Hospital Angeles Pedregal – sequence: 53 givenname: M. T. surname: Burguete Cabañas fullname: Burguete Cabañas, M. T. organization: Centro Médico Zambrano Hellion – sequence: 54 givenname: V. surname: Kvedariene fullname: Kvedariene, V. organization: Institute of Clinical Medicine – sequence: 55 givenname: A. surname: Valiulis fullname: Valiulis, A. organization: European Academy of Paediatrics (EAP/UEMS‐SP) – sequence: 56 givenname: N. H. surname: Chavannes fullname: Chavannes, N. H. organization: Leiden University Medical Center – sequence: 57 givenname: W. J. surname: Fokkens fullname: Fokkens, W. J. organization: Academic Medical Centre – sequence: 58 givenname: D. surname: Ryan fullname: Ryan, D. organization: University of Edinburgh – sequence: 59 givenname: A. surname: Sheikh fullname: Sheikh, A. organization: The University of Edinburgh – sequence: 60 givenname: C. surname: Bachert fullname: Bachert, C. organization: Ghent University Hospital – sequence: 61 givenname: P. W. surname: Hellings fullname: Hellings, P. W. organization: University of Amsterdam – sequence: 62 givenname: O. surname: VandenPlas fullname: VandenPlas, O. organization: Université Catholique de Louvain – sequence: 63 givenname: N. surname: Ballardini fullname: Ballardini, N. organization: Uppsala University – sequence: 64 givenname: I. surname: Kull fullname: Kull, I. organization: Karolinska Institutet – sequence: 65 givenname: E. surname: Melén fullname: Melén, E. organization: Karolinska Institutet – sequence: 66 givenname: M. surname: Westman fullname: Westman, M. organization: Karolinska University Hospital – sequence: 67 givenname: M. surname: Wickman fullname: Wickman, M. organization: Uppsala University – sequence: 68 givenname: C. surname: Bindslev‐Jensen fullname: Bindslev‐Jensen, C. organization: Odense University Hospital – sequence: 69 givenname: E. surname: Eller fullname: Eller, E. organization: Odense University Hospital – sequence: 70 givenname: S. surname: Bosnic‐Anticevich fullname: Bosnic‐Anticevich, S. organization: University of Sydney – sequence: 71 givenname: R. E. surname: O'Hehir fullname: O'Hehir, R. E. organization: Monash University – sequence: 72 givenname: I. surname: Agache fullname: Agache, I. organization: Transylvania University – sequence: 73 givenname: T. surname: Bieber fullname: Bieber, T. organization: Rheinische Friedrich‐Wilhelms‐University Bonn – sequence: 74 givenname: T. surname: Casale fullname: Casale, T. organization: University of South Florida – sequence: 75 givenname: B. surname: Gemicioğlu fullname: Gemicioğlu, B. organization: Istanbul University – sequence: 76 givenname: J. C. surname: Ivancevich fullname: Ivancevich, J. C. organization: Clinica Santa Isabel – sequence: 77 givenname: G. surname: De Vries fullname: De Vries, G. organization: Peercode DV – sequence: 78 givenname: M. surname: Sorensen fullname: Sorensen, M. organization: UiT The Arctic University of Norway – sequence: 79 givenname: A. surname: Yorgancioglu fullname: Yorgancioglu, A. organization: GARD Executive Committee – sequence: 80 givenname: D. surname: Laune fullname: Laune, D. organization: Kyomed |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29569295$$D View this record in MEDLINE/PubMed https://hal.science/hal-02329488$$DView record in HAL https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-366661$$DView record from Swedish Publication Index (Uppsala universitet) http://kipublications.ki.se/Default.aspx?queryparsed=id:138759419$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNp9klFvFCEQx4mpsdfTB7-AIfFFE7eFZdkF3zatWuMZH2x8JSzL3lFZuALbZr-9nHfW2KTOA5DJb_4z4T8n4Mh5pwF4idEpznEmrT3FpKrYE7DAhLOCc06PwAJhRIuKEnYMTmK8Rgg1JUfPwHHJac3zsQD9hTR2hllBh7VRcJxsMqMPnelNmqFxMGyMM8lEOEXj1nD0nbEaJq02zlu_nt_DFjp_qy1U3im9TdAPMG00_Np-_wJjmvr5OXg6SBv1i8O9BFcfP1ydXxarb58-n7erQtGasELKoVF4GHpV1Y1kPeG0qRouWVeWNZENlZQTKqteqjqnEB5o1SiO-pIRpDuyBMVeNt7p7dSJbTCjDLPw0ohD6md-aVExXqM68-8e5S_Mj1b4sBbTJEidA2f87R7fSPsPe9muxC6HSlLyirHbHftmz26Dv5l0TGI0UWlrpdN-iiIPz1CJCGEZff0AvfZTcPmfMlVzzjjOFi7BqwM1daPu7_v_cfLvdCr4GIMe7hGMxG5LRPZY_N6SzJ49YJVJMhnvUsjr8L-Ku2z-_Li0aFerfcUvm3fMbg |
| CitedBy_id | crossref_primary_10_1111_all_15371 crossref_primary_10_1002_alr_23090 crossref_primary_10_1016_j_maturitas_2019_07_023 crossref_primary_10_1111_pai_13189 crossref_primary_10_1111_all_13670 crossref_primary_10_1159_000505745 crossref_primary_10_1007_s40629_019_00110_9 crossref_primary_10_1111_all_15574 crossref_primary_10_1111_all_14204 crossref_primary_10_1111_all_13676 crossref_primary_10_2196_19194 crossref_primary_10_1016_j_jaci_2019_06_049 crossref_primary_10_1016_j_jaip_2019_07_044 crossref_primary_10_3390_ph14070658 crossref_primary_10_1002_clt2_12215 crossref_primary_10_1007_s11882_018_0824_4 crossref_primary_10_1016_j_jaip_2024_06_040 crossref_primary_10_1111_all_15740 crossref_primary_10_3390_pharmacy8020085 crossref_primary_10_2196_58309 crossref_primary_10_1002_clt2_12183 crossref_primary_10_1111_cea_14135 crossref_primary_10_1016_j_jaip_2024_03_024 crossref_primary_10_1097_ACI_0000000000000491 crossref_primary_10_1002_clt2_12208 crossref_primary_10_1038_s41598_023_39987_6 crossref_primary_10_1002_clt2_12248 crossref_primary_10_1111_all_14422 crossref_primary_10_1002_clt2_12128 crossref_primary_10_1111_all_13652 crossref_primary_10_1111_all_14586 crossref_primary_10_1016_j_jaip_2021_02_035 crossref_primary_10_1111_all_14067 crossref_primary_10_3390_jpm13050835 crossref_primary_10_1016_j_jaip_2022_08_015 crossref_primary_10_1111_all_15679 crossref_primary_10_1002_alr_22982 crossref_primary_10_1002_clt2_12298 crossref_primary_10_1002_clt2_12292 crossref_primary_10_1111_all_13617 crossref_primary_10_1016_j_pulmoe_2022_10_005 crossref_primary_10_1016_j_rmr_2019_08_003 crossref_primary_10_1177_0003489420940350 crossref_primary_10_1186_s13601_018_0227_6 crossref_primary_10_1183_13993003_00943_2022 crossref_primary_10_1186_s13601_019_0252_0 crossref_primary_10_1016_j_jaip_2022_07_020 crossref_primary_10_1111_all_16130 crossref_primary_10_1016_j_reval_2019_02_006 crossref_primary_10_1038_s41572_020_00227_0 crossref_primary_10_1080_02770903_2019_1640728 crossref_primary_10_4168_aair_2020_12_2_238 crossref_primary_10_1007_s15007_019_1938_2 crossref_primary_10_1111_cea_14479 crossref_primary_10_1007_s13555_020_00456_x crossref_primary_10_1016_j_jaci_2018_08_049 crossref_primary_10_1016_j_rmed_2023_107429 crossref_primary_10_1111_bjd_17869 crossref_primary_10_1186_s13601_019_0258_7 |
| Cites_doi | 10.3109/02770903.2013.786726 10.1111/all.12880 10.18176/jiaci.0197 10.1111/all.13125 10.1111/all.12640 10.1111/all.13177 10.1111/j.1398-9995.2007.01620.x 10.1016/S2213-2600(13)70277-7 10.1016/j.jaci.2016.03.025 10.1111/cea.13025 10.1186/s13601-017-0153-z 10.1007/s40629-016-0006-7 10.1016/j.jaci.2012.01.047 10.1016/j.jaci.2010.07.019 10.1186/s13601-017-0173-8 10.4193/Rhin17.074 10.1159/000332924 10.1016/j.jaci.2003.10.010 10.1016/S0091-6749(99)70320-9 10.1111/j.1398-9995.2008.01884.x 10.1067/mai.2001.118891 10.1159/000342991 10.1186/s13601-017-0157-8 10.1016/j.jaip.2017.09.002 10.1111/j.1398-9995.2007.01551.x 10.1016/S0140-6736(86)91008-1 10.3111/13696998.2011.576039 10.1111/j.1398-9995.2010.02534.x 10.1186/s13601-016-0137-4 |
| ContentType | Journal Article |
| Copyright | 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: Copyright © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| CorporateAuthor | MACVIA working group |
| CorporateAuthor_xml | – name: MACVIA working group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC ACNBI ADTPV AOWAS D8T DF2 ZZAVC |
| DOI | 10.1111/all.13448 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1398-9995 |
| EndPage | 1631 |
| ExternalDocumentID | oai_swepub_ki_se_489606 oai_DiVA_org_uu_366661 oai:HAL:hal-02329488v1 29569295 10_1111_all_13448 ALL13448 |
| Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Meda, The Fondation Partenariale FMC VIA LR – fundername: EU (Région Languedoc Roussillon) |
| GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 1XC ACNBI ADTPV AOWAS D8T DF2 ZZAVC |
| ID | FETCH-LOGICAL-c5638-aaf7c1ffdc467a8d3957479a8b2263a75a5935a4dac6b2201f547c90d2830eb3 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 73 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000438710600004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0105-4538 1398-9995 |
| IngestDate | Tue Nov 25 03:33:57 EST 2025 Tue Nov 04 16:40:58 EST 2025 Tue Oct 14 20:53:25 EDT 2025 Wed Oct 01 14:25:43 EDT 2025 Fri Oct 03 11:11:52 EDT 2025 Mon Jul 21 06:00:02 EDT 2025 Sat Nov 29 06:24:52 EST 2025 Tue Nov 18 21:34:58 EST 2025 Wed Jan 22 16:21:29 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | multimorbidity asthma rhinitis work productivity conjunctivitis |
| Language | English |
| License | 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5638-aaf7c1ffdc467a8d3957479a8b2263a75a5935a4dac6b2201f547c90d2830eb3 |
| Notes | Funding information The study has been funded by an unrestricted educational grant from Meda, the Fondation Partenariale FMC VIA LR and Structural and Development Funds from the EU (Région Languedoc Roussillon). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-1294-8355 0000-0003-4107-8317 0000-0001-7329-7237 0000-0001-9226-7762 0000-0002-1205-4757 0000-0003-2401-0070 0000-0002-5646-2429 0000-0002-6340-9300 0000-0001-7827-7964 0000-0003-4481-6194 0000-0002-8607-9199 |
| OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-366661 |
| PMID | 29569295 |
| PQID | 2069989145 |
| PQPubID | 34098 |
| PageCount | 10 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_489606 swepub_primary_oai_DiVA_org_uu_366661 hal_primary_oai_HAL_hal_02329488v1 proquest_miscellaneous_2018020338 proquest_journals_2069989145 pubmed_primary_29569295 crossref_primary_10_1111_all_13448 crossref_citationtrail_10_1111_all_13448 wiley_primary_10_1111_all_13448_ALL13448 |
| PublicationCentury | 2000 |
| PublicationDate | August 2018 |
| PublicationDateYYYYMMDD | 2018-08-01 |
| PublicationDate_xml | – month: 08 year: 2018 text: August 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | Denmark |
| PublicationPlace_xml | – name: Denmark – name: Zurich |
| PublicationTitle | Allergy (Copenhagen) |
| PublicationTitleAlternate | Allergy |
| PublicationYear | 2018 |
| Publisher | Blackwell Publishing Ltd Wiley |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
| References | 2017; 7 2009; 64 2017; 26 2015; 70 2017; 47 2010; 126 2016; 71 2011; 14 2001; 108 1999; 104 2013; 160 2012; 129 2017; 28(1) 2017; 72 2016; 6 1986; 1 2004; 113 2014; 2 2017; 55 2013; 50 2011; 66 2017 2016; 138 2008; 63 2007; 62 2012; 158 2014; 124 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 Hellings PW (e_1_2_8_6_1) 2017; 55 Williamson J (e_1_2_8_33_1) 2014; 124 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 e_1_2_8_30_1 |
| References_xml | – volume: 14 start-page: 305 year: 2011 end-page: 314 article-title: Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients–an observational, cross sectional study in four countries in Europe publication-title: J Med Econ – volume: 113 start-page: 86 year: 2004 end-page: 93 article-title: Association between asthma and rhinitis according to atopic sensitization in a population‐based study publication-title: J Allergy Clin Immunol – volume: 2 start-page: 131 year: 2014 end-page: 140 article-title: Comorbidity of eczema, rhinitis, and asthma in IgE‐sensitised and non‐IgE‐sensitised children in MeDALL: a population‐based cohort study publication-title: Lancet Respir Med – volume: 70 start-page: 973 year: 2015 end-page: 984 article-title: Phenotyping asthma, rhinitis and eczema in MeDALL population‐based birth cohorts: an allergic comorbidity cluster publication-title: Allergy – volume: 66 start-page: 596 year: 2011 end-page: 604 article-title: MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine publication-title: Allergy – volume: 126 start-page: 926 year: 2010 end-page: 938 article-title: Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization consultation on severe asthma publication-title: J Allergy Clin Immunol – volume: 64 start-page: 123 year: 2009 end-page: 148 article-title: Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase three publication-title: Allergy – volume: 6 start-page: 47 year: 2016 article-title: ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle publication-title: Clin Transl Allergy – volume: 47 start-page: 1526 year: 2017 end-page: 1533 article-title: Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control publication-title: Clin Exp Allergy – volume: 72 start-page: 857 year: 2017 end-page: 865 article-title: Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study publication-title: Allergy – volume: 72 start-page: 1475 year: 2017 end-page: 1484 article-title: Work productivity in rhinitis using cell phones: the MASK pilot study publication-title: Allergy – volume: 72 start-page: 1475 year: 2017 end-page: 1484 article-title: The ARIA score of allergic rhinitis using mobile technology correlates with quality‐of‐life: the MASK study publication-title: Allergy – volume: 26 start-page: 16 year: 2017 end-page: 24 article-title: Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in allergic rhinitis in everyday health care. Position paper of the German Society of Allergology publication-title: Allergo J Int – volume: 62 start-page: 1 issue: Suppl 84 year: 2007 end-page: 41 article-title: Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN publication-title: Allergy – volume: 124 start-page: 26 year: 2014 end-page: 27 article-title: Change management. Take chance out of improvement publication-title: Health Serv J – volume: 138 start-page: 367 year: 2016 end-page: 374 article-title: MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis publication-title: J Allergy Clin Immunol – year: 2017 article-title: Impact of rhinitis on work productivity: a systematic review publication-title: J Allergy Clin Immunol Pract – volume: 7 start-page: 37 year: 2017 article-title: CHRODIS criteria applied to the MASK (MACVIA‐ARIA Sentinel NetworK) good practice in allergic rhinitis: a SUNFRAIL report publication-title: Clin Transl Allergy – volume: 129 start-page: 943 year: 2012 end-page: 954 article-title: Understanding the complexity of IgE‐related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar publication-title: J Allergy Clin Immunol – volume: 55 start-page: 326 year: 2017 end-page: 331 article-title: Allergy rhinitis: similarities and differences between children and adults publication-title: Rhinology – volume: 28(1) start-page: 42 year: 2017 end-page: 44 article-title: Work productivity and activity impairment allergic specific (WPAI‐AS) questionnaire using mobile technology: the MASK study publication-title: J Investig Allergol Clin Immunol – volume: 1 start-page: 908 year: 1986 end-page: 909 article-title: Regression analysis publication-title: Lancet – volume: 55 start-page: 298 year: 2017 end-page: 304 article-title: EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis publication-title: Rhinology – volume: 63 start-page: 8 issue: Suppl 86 year: 2008 end-page: 160 article-title: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) publication-title: Allergy – volume: 71 start-page: 1513 year: 2016 end-page: 1525 article-title: Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story publication-title: Allergy – volume: 7 start-page: 17 year: 2017 article-title: Multi‐morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report publication-title: Clin Transl Allergy – volume: 160 start-page: 393 year: 2013 end-page: 400 article-title: Impact of allergic rhinitis symptoms on quality of life in primary care publication-title: Int Arch Allergy Immunol – volume: 104 start-page: 534 year: 1999 end-page: 540 article-title: Allergic rhinobronchitis: the asthma‐allergic rhinitis link publication-title: J Allergy Clin Immunol – volume: 158 start-page: 216 year: 2012 end-page: 231 article-title: Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA2LEN–ARIA position paper publication-title: Int Arch Allergy Immunol – volume: 50 start-page: 514 year: 2013 end-page: 521 article-title: Visual analog scale as a predictor of GINA‐defined asthma control. The SACRA study in Japan publication-title: J Asthma – volume: 7 start-page: 22 year: 2017 article-title: Endotype‐driven treatment in chronic upper airway diseases publication-title: Clin Transl Allergy – volume: 108 start-page: S147 year: 2001 end-page: S334 article-title: Allergic rhinitis and its impact on asthma publication-title: J Allergy Clin Immunol – volume: 55 start-page: 298 year: 2017 ident: e_1_2_8_6_1 article-title: EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis publication-title: Rhinology – ident: e_1_2_8_29_1 doi: 10.3109/02770903.2013.786726 – ident: e_1_2_8_14_1 doi: 10.1111/all.12880 – ident: e_1_2_8_32_1 doi: 10.18176/jiaci.0197 – ident: e_1_2_8_23_1 doi: 10.1111/all.13125 – ident: e_1_2_8_16_1 doi: 10.1111/all.12640 – ident: e_1_2_8_24_1 doi: 10.1111/all.13177 – ident: e_1_2_8_2_1 doi: 10.1111/j.1398-9995.2007.01620.x – ident: e_1_2_8_15_1 doi: 10.1016/S2213-2600(13)70277-7 – ident: e_1_2_8_28_1 doi: 10.1016/j.jaci.2016.03.025 – ident: e_1_2_8_20_1 doi: 10.1111/cea.13025 – ident: e_1_2_8_3_1 doi: 10.1186/s13601-017-0153-z – ident: e_1_2_8_21_1 doi: 10.1007/s40629-016-0006-7 – ident: e_1_2_8_17_1 doi: 10.1016/j.jaci.2012.01.047 – ident: e_1_2_8_27_1 doi: 10.1016/j.jaci.2010.07.019 – ident: e_1_2_8_19_1 doi: 10.1186/s13601-017-0173-8 – ident: e_1_2_8_9_1 doi: 10.4193/Rhin17.074 – ident: e_1_2_8_26_1 doi: 10.1159/000332924 – ident: e_1_2_8_5_1 doi: 10.1016/j.jaci.2003.10.010 – ident: e_1_2_8_31_1 doi: 10.1016/S0091-6749(99)70320-9 – ident: e_1_2_8_8_1 doi: 10.1111/j.1398-9995.2008.01884.x – ident: e_1_2_8_30_1 doi: 10.1067/mai.2001.118891 – ident: e_1_2_8_11_1 doi: 10.1159/000342991 – ident: e_1_2_8_7_1 doi: 10.1186/s13601-017-0157-8 – ident: e_1_2_8_12_1 doi: 10.1016/j.jaip.2017.09.002 – ident: e_1_2_8_4_1 doi: 10.1111/j.1398-9995.2007.01551.x – ident: e_1_2_8_22_1 doi: 10.1111/all.13177 – ident: e_1_2_8_25_1 doi: 10.1016/S0140-6736(86)91008-1 – ident: e_1_2_8_10_1 doi: 10.3111/13696998.2011.576039 – ident: e_1_2_8_13_1 doi: 10.1111/j.1398-9995.2010.02534.x – ident: e_1_2_8_18_1 doi: 10.1186/s13601-016-0137-4 – volume: 124 start-page: 26 year: 2014 ident: e_1_2_8_33_1 article-title: Change management. Take chance out of improvement publication-title: Health Serv J |
| SSID | ssj0007290 |
| Score | 2.5131977 |
| SecondaryResourceType | review_article |
| Snippet | Background
Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better... Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand... BackgroundMultimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better... BACKGROUND:Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better... |
| SourceID | swepub hal proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1622 |
| SubjectTerms | Adolescent Adult Aged Aged, 80 and over Allergies Allergology Asthma Child Comorbidity Conjunctivitis Female Humans Hypersensitivity - epidemiology Immunology Life Sciences Male Middle Aged Mobile Applications Multimorbidity Nose Patient Outcome Assessment Portable computers Prevalence Productivity Prospective Studies Research Design Respiratory tract diseases Rhinitis Rhinitis - epidemiology work productivity Young Adult |
| Title | Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.13448 https://www.ncbi.nlm.nih.gov/pubmed/29569295 https://www.proquest.com/docview/2069989145 https://www.proquest.com/docview/2018020338 https://hal.science/hal-02329488 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-366661 http://kipublications.ki.se/Default.aspx?queryparsed=id:138759419 |
| Volume | 73 |
| WOSCitedRecordID | wos000438710600004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 1398-9995 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 1398-9995 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb5RAEJ601RhfWn8XWy-rUeMLDRwLC_pEel5qpBejVe9tsyzQEikYrneJ_70zC0d6sSYmJjyQZYBld2b4Znf2W4CXApVE64DThibC5p7gttJjbntKK8dJNcZFhl0_EbNZOJ9Hn7bg3XotTMcPMQy4kWUYf00GrtLFNSNXVXXkehhdoP91uUu7F3z_MBu8sOjHVxA_2BytumcVoiye4c6Nf9H2BWVC_gkzBw7RTfhq_j_Tvf-q-T3Y7WEnizs9uQ9bef0A7pz2E-sPIZuosvrFaGOVFn0hM3mGl02blhnCdFbWrL0oKc9owShT_pxdNim-m10NI_NvWczqZpVXTHcrIVlTMESX7DT-8pEZFttHcDZ9f3Z8YvcbMNjaR7u0lSqEdosi0-hOVZjRnB4XkQpTBG2eEr7yI89XPFM6wCLHLXwudORkxCqGUfpj2KmbOt8HhjAFn-WgHNe0djcqUuFEqZvywCl8N7PgzbonpO7JyWmPjEqugxRsAGkazYIXg-jPjpHjRiHszuE6cWifxImkMgQp4wjd1sq14HDd27K33IUcOwFGoJHLfQueD5fR5mgiRdV5syQZ4s1zMLq34EmnJcOrxhhwIuTEu191arNRiUn5LZZNey6XS-lh5BhgJV7fINcX_cCzXPKQwkxsIqNUf_9oGSeJOXn676IHcLcbJafjEHau2mX-DG7rFSpUO4JtMQ9HcGvyefo1GRkD-w1IZCRX |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db5RAEJ-01Vhf6mcVW3U1anzBLMfCHo0vxNpcU-5i4kX7tlkWaIkUDO1d4n_vzMKRXqyJiW9kGWA_Zobf7M7-FuCNRCUxJhR0oIl0hS-Fq81IuL42mvPUYFxk2fUTOZuNT0-jLxvwcbUXpuOHGCbcyDKsvyYDpwnpa1auq-qD52N4sQm3BAINOrjh-_Fs8MOyn2FBBOEKtOueV4jyeIZH1_5Gm-eUC_kn0BxYRNcBrP0DHd37v7rfh50eebK4U5UHsJHXD-HOtF9bfwTZoS6rX4zOVmnRHTKbanjRtGmZIVJnZc3a85JSjS4ZJcufsYsmxY-zq2Fy_oDFrG6WecVMtxmSNQVDgMmm8dcTZolsH8P86PP808Ttz2BwTYCm6WpdSOMVRWbQo-pxRst6QkZ6nCJu87UMdBD5gRaZNiEWca8IhDQRz4hYDAP1Xdiqmzp_CgyRCr6Lo5wwtH03KlLJo9RLRciLwMsceL8aCmV6fnI6JqNSqzgFO0DZTnPg9SD6syPluFEIx3O4TzTakzhRVIY4ZRSh51p6Duyvhlv1xnupRjzEIDTyRODAq-E2mh2tpeg6bxYkQ9R5HAN8B550ajJ8aoQxJ6JOfPptpzdrlTgsv8Wqac_UYqF8DB5DrMS7G-T6oh94lSsxpkgTu8hq1d8breIksRfP_l30JWxP5tNEJcezkz24Sy3rMhz3YeuqXeTP4bZZonK1L6x9_QZtMCX7 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db5RAEJ-0V9P44rcWrboaNX3BwLGwh_GFeF5qSi-NVtO3zbJAS0qhob1L_O-dgb2NF2ti4htZBtiPmeE3u7O_BXgjUEm0jjgdaCJcHgjuKj3mbqC08rxMY1zUs-unYj6fnJzERxvwcbUXZuCHsBNuZBm9vyYDLy7z8jcrV3X93g8wvNiELU6HyIxga_p19j21nliYORbEEC5HyzbMQpTJYx9e-x9tnlE25J9Q0_KIrkPY_h80u_t_tb8Hdwz2ZMmgLPdho2gewPahWV1_CPlUVfVPRqerdOgQWZ9seNF2WZUjVmdVw7qzipKNrhily5-yizbDj7NrOz3_gSWsaZdFzfSwHZK1JUOIyQ6Tbwesp7J9BMezz8ef9l1zCoOrQzROV6lSaL8sc40-VU1yWtjjIlaTDJFboESowjgIFc-VjrDI88uQCx17OVGLYaj-GEZN2xQ7wBCr4Ls8lOOaNvDGZSa8OPMzHnll6OcO7K2GQmrDUE4HZdRyFalgB8i-0xx4bUUvB1qOG4VwPO19ItLeT1JJZYhUxjH6rqXvwO5quKUx3ys59iIMQ2Ofhw68srfR8Gg1RTVFuyAZIs_zMMR34MmgJvZTY4w6EXfi028HvVmrxLT6kci2O5WLhQwwfIywEu9ukDNF53hVSD6hWBO7qNeqvzdaJmnaXzz9d9GXsH00ncn0y_zgGdymhg0pjrswuu4WxXO4pZeoW90LY2C_AGQbJqQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Daily+allergic+multimorbidity+in+rhinitis+using+mobile+technology&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Bousquet%2C+J.&rft.au=Devillier%2C+P.&rft.au=Anto%2C+J.+M.&rft.au=Bewick%2C+M.&rft.date=2018-08-01&rft.issn=1398-9995&rft.volume=73&rft.issue=8&rft.spage=1622&rft_id=info:doi/10.1111%2Fall.13448&rft.externalDocID=oai_DiVA_org_uu_366661 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |